Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,994 | 437 | 100.0% |
| Education | $3.31 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,078 | 73 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $813.25 | 38 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $691.75 | 41 | $0 (2024) |
| Alkermes, Inc. | $688.92 | 33 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $634.27 | 26 | $0 (2024) |
| Lundbeck LLC | $566.92 | 29 | $0 (2024) |
| ITI, Inc. | $467.27 | 23 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $430.91 | 25 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $278.96 | 17 | $0 (2024) |
| Corium, LLC | $241.60 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,730 | 140 | Teva Pharmaceuticals USA, Inc. ($398.52) |
| 2023 | $1,962 | 108 | Otsuka America Pharmaceutical, Inc. ($233.72) |
| 2022 | $2,032 | 122 | Neurocrine Biosciences, Inc. ($220.41) |
| 2021 | $1,274 | 68 | AbbVie Inc. ($412.72) |
All Payment Transactions
438 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Bausch Health US, LLC | WELLBUTRIN (Drug), APLENZIN | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Neurology | ||||||
| 12/19/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $15.64 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $10.61 | General |
| Category: PSYCHIATRY | ||||||
| 12/17/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $9.56 | General |
| Category: CNS | ||||||
| 12/17/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $2.09 | General |
| Category: CNS | ||||||
| 12/12/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $5.80 | General |
| Category: Neuroscience | ||||||
| 12/11/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: Neuropsychiatry | ||||||
| 12/11/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $14.69 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 12/10/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $31.41 | General |
| Category: CNS | ||||||
| 12/09/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Insomnia | ||||||
| 12/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $28.03 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $17.02 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $28.60 | General |
| Category: Central Nervous System | ||||||
| 11/26/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $28.62 | General |
| Category: Neuropsychiatry | ||||||
| 11/19/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.07 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: CNS | ||||||
| 11/12/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $27.89 | General |
| Category: CNS | ||||||
| 11/08/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $2.74 | General |
| Category: PSYCHIATRY | ||||||
| 11/04/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.37 | General |
| Category: Neuropsychiatry | ||||||
| 11/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.07 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $25.63 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.51 | General |
| Category: Neuropsychiatry | ||||||
| 10/23/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.76 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 4 | 165 | 377 | $53,170 | $22,057 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 58 | 175 | $26,250 | $12,101 | 46.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 50 | 128 | $15,360 | $5,609 | 36.5% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 37 | 54 | $7,560 | $2,376 | 31.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 20 | 20 | $4,000 | $1,971 | 49.3% |
About Marco Katada
Marco Katada is a Psychiatric/Mental Health healthcare provider based in Garden City, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/23/2014. The National Provider Identifier (NPI) number assigned to this provider is 1003224932.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Marco Katada has received a total of $7,997 in payments from pharmaceutical and medical device companies, with $2,730 received in 2024. These payments were reported across 438 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($7,994).
As a Medicare-enrolled provider, Katada has provided services to 165 Medicare beneficiaries, totaling 377 services with total Medicare billing of $22,057. Data is available for 1 year (2020–2020), covering 4 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Location Garden City, KS
- Active Since 07/23/2014
- Last Updated 07/23/2014
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1003224932
Products in Payments
- VRAYLAR (Drug) $1,078
- INGREZZA (Drug) $813.25
- CAPLYTA (Drug) $746.23
- Austedo XR (Drug) $559.44
- ARISTADA (Drug) $505.49
- REXULTI (Drug) $490.98
- ABILIFY MAINTENA (Drug) $255.53
- BRINTELLIX (Drug) $240.33
- SPRAVATO (Drug) $222.82
- ABILIFY ASIMTUFII (Drug) $216.00
- BELSOMRA (Drug) $213.26
- INVEGA SUSTENNA (Drug) $195.64
- TRINTELLIX (Drug) $184.12
- Azstarys (Drug) $163.32
- LYBALVI (Drug) $154.70
- LATUDA (Drug) $152.78
- Secuado (Drug) $148.14
- WELLBUTRIN (Drug) $141.76
- LOREEV XR (Drug) $120.27
- QUVIVIQ (Drug) $117.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Garden City
Tashonna Webster, Phd, Pmhnp, Mph, Ms, PHD, PMHNP, MPH, MS
Psychiatric/Mental Health — Payments: $3,839
Allen Sutton, Npp, NPP
Psychiatric/Mental Health — Payments: $1,935
Nisha Pradeep
Psychiatric/Mental Health — Payments: $911.36
Elizabeth Gant, Arnp, ARNP
Psychiatric/Mental Health — Payments: $855.14
Mr. Brad Lieberman, Np, NP
Psychiatric/Mental Health — Payments: $456.21
Christine Guebara, Arnp, ARNP
Psychiatric/Mental Health — Payments: $433.34